AIMD
Ainos, Inc.NASDAQHealthcare$1.49+3.47%ClosedMarket Cap: $6.4M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.84
P/S
51.38
EV/EBITDA
-1.83
DCF Value
$-2.66
FCF Yield
-72.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
82.9%
Operating Margin
-11268.3%
Net Margin
-11897.0%
ROE
-140.1%
ROA
-70.8%
ROIC
-70.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $11.1K | 85.6% | $-4.3M | $-4.5M | $205.32 | — |
| FY 2025 | $124.2K | 82.9% | $-14.0M | $-14.8M | $-3.46 | — |
| Q3 2025 | $2.2K | 78.0% | $-2.8M | $-2.9M | $-0.64 | — |
| Q2 2025 | $4.7K | 79.9% | $-3.7M | $-4.1M | $-0.99 | — |
| Q1 2025 | $106.2K | 82.8% | $-3.2M | $-3.3M | $-207.15 | — |
| Q4 2024 | $0.00 | Infinity% | $-4.6M | $-4.7M | $-0.49 | — |
| FY 2024 | $20.7K | -153.7% | $-13.8M | $-14.9M | $-1.56 | — |
| Q3 2024 | $0.00 | -Infinity% | $-3.0M | $-3.7M | $-0.33 | — |
| Q2 2024 | $0.00 | -Infinity% | $-3.0M | $-3.2M | $-0.49 | — |
| Q1 2024 | $20.7K | -29.1% | $-3.1M | $-3.3M | $-0.57 | — |
| Q4 2023 | $19.9K | -559.7% | $-5.7M | $-5.9M | $-1.37 | — |
| FY 2023 | $122.1K | -207.8% | $-13.2M | $-13.8M | $-3.36 | — |